Predictions
Athersys Inc.
Start price
Target price
Perf. (%)
€23.38
30.11.21
30.11.21
€25.00
30.11.22
30.11.22
-71.89%
07.07.22
07.07.22
Could be worthwhile Investment >10% per year
Innovative
Few uniques
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.80
13.11.21
13.11.21
€50.00
31.12.23
31.12.23
11.71%
29.06.22
29.06.22
Could be very worthwhile Investment >20% year
Agile Therapeutics Inc.
Start price
Target price
Perf. (%)
€79.50
27.06.22
27.06.22
€100.00
27.06.23
27.06.23
40.88%
28.06.22
28.06.22
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Kezar Life Sciences
Start price
Target price
Perf. (%)
€10.20
16.11.21
16.11.21
€11.00
31.12.24
31.12.24
0.98%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Otonomy Inc.
Start price
Target price
Perf. (%)
€1.67
25.10.21
25.10.21
€3.00
31.12.23
31.12.23
21.68%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€28.20
30.08.21
30.08.21
€50.00
31.12.23
31.12.23
63.83%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.00
26.06.21
26.06.21
-
26.06.22
26.06.22
-81.82%
27.06.22
27.06.22
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.10
13.06.22
13.06.22
€1.00
13.06.23
13.06.23
7.81%
25.06.22
25.06.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.30
01.04.20
01.04.20
€4.88
24.10.24
24.10.24
-47.02%
13.06.22
13.06.22
MacroGenics Inc.
Start price
Target price
Perf. (%)
€3.28
29.05.22
29.05.22
-
29.05.23
29.05.23
-25.00%
12.06.22
12.06.22
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€42.57
03.06.22
03.06.22
-
03.06.23
03.06.23
-9.55%
11.06.22
11.06.22
Risky Investment
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.81
14.03.22
14.03.22
€6.40
14.03.23
14.03.23
-33.68%
11.06.22
11.06.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.19
30.05.22
30.05.22
-
30.05.23
30.05.23
-7.79%
11.06.22
11.06.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.29
29.05.22
29.05.22
-
29.05.23
29.05.23
-0.67%
09.06.22
09.06.22
Could be very worthwhile Investment >20% year
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€114.10
07.01.22
07.01.22
€130.00
07.01.23
07.01.23
-63.63%
05.06.22
05.06.22
Could be worthwhile Investment >10% per year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.74
31.05.21
31.05.21
€15.00
31.05.22
31.05.22
-60.61%
01.06.22
01.06.22
Fair valuation
Strong uniques
Leading role in innovation
Bad rating